CONTRACT, DEVELOPMENT, AND MANUFACTURING

HHBT Labs operates an aseptic GMP manufacturing facility capable of producing clinical or commercial materials on a CDMO basis. We have robust quality assurance procedures in place and are currently working on three ophthalmic formulation projects slated for a 2022/23 release. Please contact us to discuss your project requirements.
Our mission is to develop and deliver cost-effective, high-quality therapeutics for patients in critical need.